{"slug":"pharmazell","name":"PharmaZell","url":"https://www.gp-intel.com/company/pharmazell","sector":"Pharma","country":"Germany","hq_city":null,"website":null,"founded_year":null,"ipo_year":null,"status":"pe_owned","current_owner":"Bridgepoint","current_holder":{"name":"Bridgepoint","names":["Bridgepoint"],"since_year":2020,"basis":"active_investor"},"ownership_periods":4,"ownership":[{"owner":"Auctus Capital Partners","fund":"Auctus I (Evergreen)","fund_vintage":2003,"entry_year":2006,"exit_year":2011,"is_exit":true,"deal_type":"Secondary","buyer":"Ergon Capital Partners","moic":null,"sector":"Pharma"},{"owner":"DPE Deutsche Private Equity","fund":"DPE Fund II","fund_vintage":2013,"entry_year":2014,"exit_year":2020,"is_exit":true,"deal_type":"Secondary","buyer":"Bridgepoint","moic":null,"sector":"Pharma"},{"owner":"Maxburg Capital Partners","fund":"Maxburg Beteiligungen","fund_vintage":2014,"entry_year":2014,"exit_year":2020,"is_exit":true,"deal_type":"Secondary","buyer":"Bridgepoint","moic":null,"sector":"Pharma"},{"owner":"Bridgepoint","fund":"Europe VI (BE VI)","fund_vintage":2017,"entry_year":2020,"exit_year":null,"is_exit":false,"deal_type":null,"buyer":null,"moic":null,"sector":"Pharma"}],"source":"gp-intel.com","license":"CC-BY-4.0","updated_at":"2026-07-03T05:01:03.207Z"}